Raunkilde, L.; Hansen, T.F.; Andersen, R.F.; Havelund, B.M.; Thomsen, C.B.; Jensen, L.H.
NPY Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer. Cancers 2022, 14, 4459.
https://doi.org/10.3390/cancers14184459
AMA Style
Raunkilde L, Hansen TF, Andersen RF, Havelund BM, Thomsen CB, Jensen LH.
NPY Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer. Cancers. 2022; 14(18):4459.
https://doi.org/10.3390/cancers14184459
Chicago/Turabian Style
Raunkilde, Louise, Torben Frøstrup Hansen, Rikke Fredslund Andersen, Birgitte Mayland Havelund, Caroline Brenner Thomsen, and Lars Henrik Jensen.
2022. "NPY Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer" Cancers 14, no. 18: 4459.
https://doi.org/10.3390/cancers14184459
APA Style
Raunkilde, L., Hansen, T. F., Andersen, R. F., Havelund, B. M., Thomsen, C. B., & Jensen, L. H.
(2022). NPY Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer. Cancers, 14(18), 4459.
https://doi.org/10.3390/cancers14184459